10 research outputs found
Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments
The purpose of this project was to conduct a systematic review to identify instruments designed to evaluate the quality of randomized controlled trials (RCTs) of natural health products (NHPs). Instruments were examined for inclusion of items assessing methods, identity and content of the NHP, generalizability of results and instructions for use. Online databases, websites, textbooks and reference lists were searched to identify instruments. Relevance assessment and data extraction of articles were completed by two investigators and disagreements were settled by the third investigator. Data were analyzed using descriptive statistics. Of the 4442 citations identified, 29 were potentially relevant with 16 meeting the criteria for inclusion. None of the instruments stated they were validated; content in the four areas of interest varied considerably. The most common items included randomization sequence generation (100%), blinding (100%), allocation concealment (75%) and participant flow (75%). Only nine of the NHP instruments included at least one item to appraise the specific content of the NHP. The CONSORT Statement for Herbal Interventions most closely addressed the four areas of interest; however, this instrument was specific for herbs. There is a need for the development of a validated instrument for assessment of the quality of RCTs that would be useful for herbs as well as other NHPs
Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products
<p>Abstract</p> <p>Background</p> <p>The efficacy of natural products (NPs) is being evaluated using randomized controlled trials (RCTs) with increasing frequency, yet a search of the literature did not identify a widely accepted critical appraisal instrument developed specifically for use with NPs. The purpose of this project was to develop and evaluate a critical appraisal instrument that is sufficiently rigorous to be used in evaluating RCTs of conventional medicines, and also has a section specific for use with single entity NPs, including herbs and natural sourced chemicals.</p> <p>Methods</p> <p>Three phases of the project included: 1) using experts and a Delphi process to reach consensus on a list of items essential in describing the identity of an NP; 2) compiling a list of non-NP items important for evaluating the quality of an RCT using systematic review methodology to identify published instruments and then compiling item categories that were part of a validated instrument and/or had empirical evidence to support their inclusion and 3) conducting a field test to compare the new instrument to a published instrument for usefulness in evaluating the quality of 3 RCTs of a NP and in applying results to practice.</p> <p>Results</p> <p>Two Delphi rounds resulted in a list of 15 items essential in describing NPs. Seventeen item categories fitting inclusion criteria were identified from published instruments for conventional medicines. The new assessment instrument was assembled based on content of the two lists and the addition of a Reviewer's Conclusion section. The field test of the new instrument showed good criterion validity. Participants found it useful in translating evidence from RCTs to practice.</p> <p>Conclusion</p> <p>A new instrument for the critical appraisal of RCTs of NPs was developed and tested. The instrument is distinct from other available assessment instruments for RCTs of NPs in its systematic development and validation. The instrument is ready to be used by pharmacy students, health care practitioners and academics and will continue to be refined as required.</p
Defining bioidentical hormones for menopause-related symptoms
In the last decade, the use of bioidentical hormones
(BHs) to treat menopause-related symptoms has
become increasingly popular. However, the many
different definitions of BHs have led to a great deal
of confusion often making it difficult for health care
providers to discuss this area with patients.
Objective: The purpose of this paper was to
produce a concise definition of bioidentical
hormones, based on a review of the literature.
Methods: Searches, using systematic review
methodology, were conducted from inception to
June 2010 in PubMed, EMBASE, IPA, The Journal
of International Compounding and the Internet to
identify definitions of bioidentical hormones. There
were no restrictions on type, date or language of
publication. Included papers/website included those
that contained a definition of BHs. Definitions were
extracted, similarities and differences summarized,
and these were then examined to produce a
concise definition.
Results: Sixty-three definitions were found. Based
on the analysis of similarities and differences, the
following definition, comprised of three components
(term being defined; category to which term
belongs; distinctive characteristics of term) was
produced: "Bioidentical hormones are chemical
substances that are identical in molecular structure
to human hormones".
Conclusions: This definition clearly and concisely
explains the meaning of BHs which should lead to a
common understanding of the term and limit
confusion among health care providers, the general
public and the scientific community.En la década pasada, se ha vuelto popular el uso de
hormonas bioidenticas (HB) para tratar los
sÃntomas asociados a la menopausia. Sin embargo,
las muchas definiciones de HB han llevado a una
gran confusión haciendo, a menudo, difÃcil para los
profesionales de la salud discutir esto con los
pacientes.
Objetivo: El propósito de este artÃculo es producir
una definición concisa de hormonas bioidenticas,
basándose en una revisión de la literatura.
Métodos: Para identificar definiciones de HB, sSe
realizaron búsquedas en PubMed, EMBASE, IPA,
Journal of International Compounding e Internet
desde su inicio hasta junio de 2010, utilizando
metodologÃa de revisión sistemática. No hubo
restricciones en cuanto al tipo, fecha o idioma de
las publicaciones. Los artÃculos/páginas web
incluidas comprendÃan aquellas que contenÃan una
definición de HB. Se extrajeron las definiciones, y
se resumieron las similitudes y diferencias, y
después se examinaron éstas para producir una
definición concisa.
Resultados: Se encontraron 63 definiciones.
Basándose en el análisis de similitudes y
diferencias, se produjo la siguiente definición, que
comprendÃa tres componentes (término bien
definido; categorÃa a la que pertenece el término;
caracterÃsticas distintivas del término): "Hormonas
bioidenticas son substancias quÃmicas que son
idénticas en estructura molecular a las hormonas
humanas".
Conclusiones: Esta definición explica clara y
resumidamente el significado de HB lo que deberÃa
llevar a un entendimiento común del término y
reducir la confusión entre los profesionales de la
salud, el público en general y la comunidad
cientÃfica
Bioidentical hormone therapy: Nova Scotia pharmacists´ knowledge and beliefs
Objectives: To investigate Nova Scotia (NS)
pharmacists´ knowledge and beliefs regarding the
use of bioidentical hormones (BHs) for the
management of menopause related symptoms.
Methods: Using Dillman´s tailored design
methodology, an invitation to complete the webbased
questionnaire was emailed to pharmacists in
NS as part of the Dalhousie College of Pharmacy
Continuing Pharmacy Education Department´s
(CPE) weekly email update. Data was analyzed
using descriptive statistics.
Results: Of approximately 1300 e-mails sent, 113
pharmacists completed the questionnaire (response
rate 8.7%). The majority of respondents (94%) knew
that BHs were not free from adverse drug reactions.
More than 50% were aware that conjugated equine
estrogens and medroxyprogesterone acetate were
not examples of BHs. For seven of eleven
knowledge questions, 33-45% indicated that they
did not know the answer. When asked about their
beliefs regarding BHs, many believed that BHs were
similar in efficacy (49%) or more effective (21%)
than conventional hormone therapy (CHT) for
vasomotor symptoms. Most respondents also
believed that both BHs and CHT had similar safety
profiles. Additionally, responding pharmacists
indicated that more education would be helpful,
especially in the area of safety and efficacy of BHTs
compared to CHT.
Conclusion: NS pharmacists knew BHs were not
free of adverse effects, however knowledge was
lacking in other areas. This may reflect the level of
coverage of this topic in pharmacy school
curriculums and in the pharmacy literature. Results
indicate a need for additional education of NS
pharmacists with respect to BHs, which could be
accomplished through modification of
undergraduate pharmacy programs and
supplementary CPE.Objetivos: Investigar los conocimientos y
creencias de los farmacéuticos de Nueva Escocia
(NS) sobre el uso de hormonas bioidénticas (BH)
para el manejo de los sÃntomas relacionados con la
menopausia.
Métodos: Utilizando el diseño metodológico de
Dillman, se envió por email a los farmacéuticos de
NS una invitación a completar un cuestionario
online como parte de las actualizaciones semanales
del Departamento de Formación Continua de la
Facultad de Farmacia de la Universidad de
Dalhousie. Los datos se analizaron con estadÃstica
descriptiva.
Resultados: De los aproximadamente 1300 emails
enviados, 113 farmacéuticos completaron el
cuestionario (tasa de respuesta 8,7%). La mayorÃa
de los respondientes (94%) sabÃan que las BH no
estaban libres de reacciones adversas. Más del 50%
conocÃan que los estrógenos conjugados equinos y
la medroxiprogesterona acetato no eran ejemplos de
BH. Para 7 de las 11 preguntas, del 33-45% indicó
que no conocÃa la respuesta. Cuando se les
preguntó sobre sus creencias sobre las BH, muchos
creÃan que las BH eran similares en eficacia (49%)
o más eficaces (21%) que la terapia hormonal
convencional (CHT) para los sÃntomas
vasomotores. La mayorÃa de los respondientes
también creÃan que las BH y las CHT tenÃan
perfiles de seguridad similares. Además, los
farmacéuticos respondientes indicaron que serÃa útil
más educación, especialmente en el área de
seguridad y eficacia de las BH comparadas con las
CHT.
Conclusión: Los farmacéuticos de NS sabÃan que
las BH no estaban libres de efectos adversos, sin
embargo carecÃan de conocimientos en otras áreas.
Esto puede reflejar la cobertura de este asunto en
los currÃculos de las facultades de farmacia y en la
literatura farmacéutica. Los resultados indican una
necesidad de educación adicional de los
farmacéuticos de NS en relación a las BH, lo que
podrÃa conseguirse mediante la modificación de los
programas de pregrado y la formación continua
suplementaria
Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups
Background:
Natural health products (NHPs) such as herbs, vitamins and homeopathic medicines, are currently available for sale in most Canadian pharmacies. However, most pharmacists report that they have limited knowledge about these products which have been regulated in Canada as a specific sub-category of drugs. In this paper, consumers' and practicing pharmacists' perceptions of pharmacists' professional responsibilities with respect to NHPs are examined.
Methods
A total of 16 focus groups were conducted with consumers (n = 50) and pharmacists (n = 47) from four different cities across Canada (Vancouver, Edmonton, Toronto, and Halifax).
Results
In this paper, we illustrate the ways in which pharmacists' professional responsibilities are impacted by changing consumer needs. Many consumers in the study utilized a wide range of information resources that may or may not have included pharmacists. Nevertheless, the majority of consumers and pharmacists agreed that pharmacists should be knowledgeable about NHPs and felt that pharmacists should be able to manage drug-NHPs interactions as well as identify and evaluate the variety of information available to help consumers make informed decisions.
Conclusion
This paper demonstrates that consumers' expectations and behaviour significantly impact pharmacists' perceptions of their professional responsibilities with respect to NHPs.Pharmaceutical Sciences, Faculty ofNon UBCReviewedFacult